Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maribavir for CMV Infection in Children and Adolescents Post-Transplant
NCT05319353Phase 3Recruiting
- Sponsor
- Takeda
- Start
- Nov 2023
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of maribavir in cytomegalovirus infection (CMV), sponsored by Takeda. Started Nov 2023; status: recruiting.
02
Drugs
maribavir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT05319353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05319353.